UA10095A - Agent for improvement of organism total radioresistance - Google Patents

Agent for improvement of organism total radioresistance

Info

Publication number
UA10095A
UA10095A UA93006980A UA93006980A UA10095A UA 10095 A UA10095 A UA 10095A UA 93006980 A UA93006980 A UA 93006980A UA 93006980 A UA93006980 A UA 93006980A UA 10095 A UA10095 A UA 10095A
Authority
UA
Ukraine
Prior art keywords
radioresistance
improvement
agent
organism total
organism
Prior art date
Application number
UA93006980A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Людмила Абрамівна Френкель
Людмила Абрамовна Френкель
Валентин Олександрович Оридорога
Валентин Александрович Оридорога
Світлана Миколаївна Бекетова
Светлана Николаевна Бекетова
Лариса Павлівна Безугла
Лариса Павловна Безугла
Валентина Григорівна Тимченко
Валентина Григорьевна Тимченко
Original Assignee
Харківський Науково-Дослідний Інститут Медичної Радіології
Харьковский Научно-Исследовательский Институт Медицинской Радиологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Науково-Дослідний Інститут Медичної Радіології, Харьковский Научно-Исследовательский Институт Медицинской Радиологии filed Critical Харківський Науково-Дослідний Інститут Медичної Радіології
Priority to UA93006980A priority Critical patent/UA10095A/en
Publication of UA10095A publication Critical patent/UA10095A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to medicine. Calcium-sodium alginate is used at a dose of 100 – 500 mg per a 1 kg of body weight as an agent for improvement of organism total radioresistance.
UA93006980A 1993-06-11 1993-06-11 Agent for improvement of organism total radioresistance UA10095A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA93006980A UA10095A (en) 1993-06-11 1993-06-11 Agent for improvement of organism total radioresistance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA93006980A UA10095A (en) 1993-06-11 1993-06-11 Agent for improvement of organism total radioresistance

Publications (1)

Publication Number Publication Date
UA10095A true UA10095A (en) 1996-09-30

Family

ID=74594334

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93006980A UA10095A (en) 1993-06-11 1993-06-11 Agent for improvement of organism total radioresistance

Country Status (1)

Country Link
UA (1) UA10095A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2694222C2 (en) * 2019-04-19 2019-07-10 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Method for preventing and treating acute radiation injury

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2694222C2 (en) * 2019-04-19 2019-07-10 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Method for preventing and treating acute radiation injury

Similar Documents

Publication Publication Date Title
BE2018C038I2 (en)
EP0564924A3 (en) 2-oxoethyl derivatives as immunosuppressants
NZ514077A (en) Treatment of Α-galactosidase A deficiency
NZ229891A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
AU7549496A (en) (S)-(+)-hydroxychloroquine
UA10095A (en) Agent for improvement of organism total radioresistance
EP0437929A3 (en) Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
HU9204028D0 (en) Medical preparative for treatment of diseases of mamma
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
EP0738154A4 (en) N-terminus modified analogs of lhrh
AU683098B2 (en) Carcinostatic for hormonotherapy containing dienogest as effective component
AU8602391A (en) Therapeutic device for correcting misalignment of center of gravity of human body
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
EP0353910A3 (en) Human interferon-gamma, process for preparing said human interferon-gamma, and its use
CA2188871A1 (en) Method for Treating Psoriasis
ES2027507A6 (en) Selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
EP0457336A3 (en) Use of mizoribine for the treatment or prevention of multiple sclerosis
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
UA7190A (en) Method for treating pyo-inflammatory processes in lungs
IE891758L (en) Therapeutic uses of 2', 5'-oligoadenylates
IL106709A0 (en) Therapeutic uses of 2',5'-oligoadenylates